These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2903220)

  • 21. Neuroleptic-induced extrapyramidal symptoms and serum calcium levels. Results of a pilot study.
    Kuny S; Binswanger U
    Neuropsychobiology; 1989; 21(2):67-70. PubMed ID: 2575718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment.
    Modestin J; Wehrli MV; Stephan PL; Agarwalla P
    Schizophr Res; 2008 Mar; 100(1-3):97-107. PubMed ID: 18055180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative assessment of neuroleptic-induced extrapyramidal symptoms: clinical and nonclinical approaches.
    May PR; Lee MA; Bacon RC
    Clin Neuropharmacol; 1983; 6 Suppl 1():S35-51. PubMed ID: 6139165
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuroleptic induced extrapyramidal symptoms.
    Donlon PT; Stenson RL
    Dis Nerv Syst; 1976 Nov; 37(11):629-35. PubMed ID: 136337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of propranolol in a patient with tardive dyskinesia and extrapyramidal syndrome.
    Chaudhry R; Radonjic D; Waters B
    Am J Psychiatry; 1982 May; 139(5):674-6. PubMed ID: 6122382
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms.
    Bezchlibnyk-Butler KZ; Remington GJ
    Can J Psychiatry; 1994 Mar; 39(2):74-84. PubMed ID: 7908605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM; Annable L; Bélanger MC; Chouinard G
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible lithium-induced extrapyramidal effects in Alzheimer's disease.
    Randels PM; Marco LA; Hanspal NS; Robinson B
    Hillside J Clin Psychiatry; 1984; 6(1):117-21. PubMed ID: 6571454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Algorithms for the treatment of acute side effects induced by neuroleptics.
    Kusumi I; Koyama T
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S19-22. PubMed ID: 10560893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Finger tremor and extrapyramidal side effects of neuroleptic drugs.
    Collins P; Lee I; Tyrer P
    Br J Psychiatry; 1979 May; 134():488-93. PubMed ID: 38876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extrapyramidal side effects in patients with Alzheimer's disease treated with low-dose neuroleptic medication.
    Caligiuri MP; Rockwell E; Jeste DV
    Am J Geriatr Psychiatry; 1998; 6(1):75-82. PubMed ID: 9469217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extrapyramidal side effects with atypical neuroleptics in bipolar disorder.
    Ghaemi SN; Hsu DJ; Rosenquist KJ; Pardo TB; Goodwin FK
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):209-13. PubMed ID: 16412546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Painful sensory symptoms in neuroleptic-induced extrapyramidal syndromes.
    Decina P; Mukherjee S; Caracci G; Harrison K
    Am J Psychiatry; 1992 Aug; 149(8):1075-80. PubMed ID: 1353315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroleptics, extrapyramidal symptoms, and serum-calcium levels.
    el-Defrawi MH; Craig TJ
    Compr Psychiatry; 1984; 25(6):539-45. PubMed ID: 6150808
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of piracetam on extrapyramidal side effects induced by neuroleptic drugs.
    Kabes J; Sikora J; Pisvejc J; Hanzlicek L; Skondia V
    Int Pharmacopsychiatry; 1982; 17(3):185-92. PubMed ID: 6128331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ionized calcium and neuroleptic-induced extrapyramidal symptoms.
    Kuny S; Binswanger U
    Pharmacopsychiatry; 1988 Nov; 21(6):300-1. PubMed ID: 2907631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Shakuyaku-Kanzo-to on Extrapyramidal Symptoms During Antipsychotic Treatment: A Randomized, Open-Label Study.
    Ota T; Miura I; Kanno-Nozaki K; Hoshino H; Horikoshi S; Fujimori H; Kanno T; Mashiko H; Yabe H
    J Clin Psychopharmacol; 2015 Jun; 35(3):304-7. PubMed ID: 25839338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extrapyramidal syndromes in nonhuman primates: typical and atypical neuroleptics.
    Casey DE
    Psychopharmacol Bull; 1991; 27(1):47-50. PubMed ID: 1677773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Iatrogenic extrapyramidal disorders].
    Ludin HP
    Schweiz Med Wochenschr; 1990 Jun; 120(23):855-8. PubMed ID: 1972812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.